Highlights

[PHARMA] YoY Quarter Result on 2013-09-30 [#3]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 19-Nov-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 30-Sep-2013  [#3]
Profit Trend QoQ -     -36.04%    YoY -     -85.14%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 515,215 524,413 502,086 440,807 426,460 371,432 334,337 7.47%
  YoY % -1.75% 4.45% 13.90% 3.36% 14.82% 11.10% -
  Horiz. % 154.10% 156.85% 150.17% 131.85% 127.55% 111.10% 100.00%
PBT 19,923 25,337 24,945 13,461 28,493 15,646 15,405 4.38%
  YoY % -21.37% 1.57% 85.31% -52.76% 82.11% 1.56% -
  Horiz. % 129.33% 164.47% 161.93% 87.38% 184.96% 101.56% 100.00%
Tax -7,275 -5,362 -9,944 -9,291 -2,957 -4,687 -6,970 0.72%
  YoY % -35.68% 46.08% -7.03% -214.20% 36.91% 32.75% -
  Horiz. % 104.38% 76.93% 142.67% 133.30% 42.42% 67.25% 100.00%
NP 12,648 19,975 15,001 4,170 25,536 10,959 8,435 6.98%
  YoY % -36.68% 33.16% 259.74% -83.67% 133.01% 29.92% -
  Horiz. % 149.95% 236.81% 177.84% 49.44% 302.74% 129.92% 100.00%
NP to SH 13,061 19,971 14,955 3,751 25,247 10,811 8,586 7.23%
  YoY % -34.60% 33.54% 298.69% -85.14% 133.53% 25.91% -
  Horiz. % 152.12% 232.60% 174.18% 43.69% 294.05% 125.91% 100.00%
Tax Rate 36.52 % 21.16 % 39.86 % 69.02 % 10.38 % 29.96 % 45.25 % -3.51%
  YoY % 72.59% -46.91% -42.25% 564.93% -65.35% -33.79% -
  Horiz. % 80.71% 46.76% 88.09% 152.53% 22.94% 66.21% 100.00%
Total Cost 502,567 504,438 487,085 436,637 400,924 360,473 325,902 7.48%
  YoY % -0.37% 3.56% 11.55% 8.91% 11.22% 10.61% -
  Horiz. % 154.21% 154.78% 149.46% 133.98% 123.02% 110.61% 100.00%
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.81%
  YoY % -0.58% 5.37% 7.12% -4.65% 6.98% 9.33% -
  Horiz. % 125.15% 125.89% 119.47% 111.52% 116.96% 109.33% 100.00%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 10,365 23,312 20,698 7,760 11,764 - - -
  YoY % -55.54% 12.63% 166.72% -34.03% 0.00% 0.00% -
  Horiz. % 88.11% 198.16% 175.94% 65.97% 100.00% - -
Div Payout % 79.37 % 116.73 % 138.41 % 206.90 % 46.60 % - % - % -
  YoY % -32.01% -15.66% -33.10% 343.99% 0.00% 0.00% -
  Horiz. % 170.32% 250.49% 297.02% 443.99% 100.00% - -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.81%
  YoY % -0.58% 5.37% 7.12% -4.65% 6.98% 9.33% -
  Horiz. % 125.15% 125.89% 119.47% 111.52% 116.96% 109.33% 100.00%
NOSH 259,146 259,027 258,737 258,689 117,646 106,933 106,924 15.88%
  YoY % 0.05% 0.11% 0.02% 119.89% 10.02% 0.01% -
  Horiz. % 242.37% 242.25% 241.98% 241.94% 110.03% 100.01% 100.00%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.45 % 3.81 % 2.99 % 0.95 % 5.99 % 2.95 % 2.52 % -0.47%
  YoY % -35.70% 27.42% 214.74% -84.14% 103.05% 17.06% -
  Horiz. % 97.22% 151.19% 118.65% 37.70% 237.70% 117.06% 100.00%
ROE 2.46 % 3.74 % 2.95 % 0.79 % 5.09 % 2.33 % 2.02 % 3.34%
  YoY % -34.22% 26.78% 273.42% -84.48% 118.45% 15.35% -
  Horiz. % 121.78% 185.15% 146.04% 39.11% 251.98% 115.35% 100.00%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 198.81 202.45 194.05 170.40 362.49 347.35 312.69 -7.26%
  YoY % -1.80% 4.33% 13.88% -52.99% 4.36% 11.08% -
  Horiz. % 63.58% 64.74% 62.06% 54.49% 115.93% 111.08% 100.00%
EPS 5.04 7.71 5.78 1.45 21.46 10.11 8.03 -7.46%
  YoY % -34.63% 33.39% 298.62% -93.24% 112.27% 25.90% -
  Horiz. % 62.76% 96.01% 71.98% 18.06% 267.25% 125.90% 100.00%
DPS 4.00 9.00 8.00 3.00 10.00 0.00 0.00 -
  YoY % -55.56% 12.50% 166.67% -70.00% 0.00% 0.00% -
  Horiz. % 40.00% 90.00% 80.00% 30.00% 100.00% - -
NAPS 2.0500 2.0630 1.9600 1.8300 4.2200 4.3400 3.9700 -10.42%
  YoY % -0.63% 5.26% 7.10% -56.64% -2.76% 9.32% -
  Horiz. % 51.64% 51.96% 49.37% 46.10% 106.30% 109.32% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 197.23 200.75 192.20 168.74 163.25 142.19 127.99 7.47%
  YoY % -1.75% 4.45% 13.90% 3.36% 14.81% 11.09% -
  Horiz. % 154.10% 156.85% 150.17% 131.84% 127.55% 111.09% 100.00%
EPS 5.00 7.64 5.72 1.44 9.66 4.14 3.29 7.22%
  YoY % -34.55% 33.57% 297.22% -85.09% 133.33% 25.84% -
  Horiz. % 151.98% 232.22% 173.86% 43.77% 293.62% 125.84% 100.00%
DPS 3.97 8.92 7.92 2.97 4.50 0.00 0.00 -
  YoY % -55.49% 12.63% 166.67% -34.00% 0.00% 0.00% -
  Horiz. % 88.22% 198.22% 176.00% 66.00% 100.00% - -
NAPS 2.0336 2.0456 1.9413 1.8122 1.9005 1.7766 1.6250 3.81%
  YoY % -0.59% 5.37% 7.12% -4.65% 6.97% 9.33% -
  Horiz. % 125.14% 125.88% 119.46% 111.52% 116.95% 109.33% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 5.5800 6.5000 4.6300 4.8200 7.5500 5.9000 4.9800 -
P/RPS 2.81 3.21 2.39 2.83 2.08 1.70 1.59 9.95%
  YoY % -12.46% 34.31% -15.55% 36.06% 22.35% 6.92% -
  Horiz. % 176.73% 201.89% 150.31% 177.99% 130.82% 106.92% 100.00%
P/EPS 110.71 84.31 80.10 332.41 35.18 58.36 62.02 10.13%
  YoY % 31.31% 5.26% -75.90% 844.88% -39.72% -5.90% -
  Horiz. % 178.51% 135.94% 129.15% 535.97% 56.72% 94.10% 100.00%
EY 0.90 1.19 1.25 0.30 2.84 1.71 1.61 -9.23%
  YoY % -24.37% -4.80% 316.67% -89.44% 66.08% 6.21% -
  Horiz. % 55.90% 73.91% 77.64% 18.63% 176.40% 106.21% 100.00%
DY 0.72 1.38 1.73 0.62 1.32 0.00 0.00 -
  YoY % -47.83% -20.23% 179.03% -53.03% 0.00% 0.00% -
  Horiz. % 54.55% 104.55% 131.06% 46.97% 100.00% - -
P/NAPS 2.72 3.15 2.36 2.63 1.79 1.36 1.25 13.82%
  YoY % -13.65% 33.47% -10.27% 46.93% 31.62% 8.80% -
  Horiz. % 217.60% 252.00% 188.80% 210.40% 143.20% 108.80% 100.00%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 -
Price 5.7000 6.5000 4.4500 4.7200 8.2500 5.9000 4.9200 -
P/RPS 2.87 3.21 2.29 2.77 2.28 1.70 1.57 10.57%
  YoY % -10.59% 40.17% -17.33% 21.49% 34.12% 8.28% -
  Horiz. % 182.80% 204.46% 145.86% 176.43% 145.22% 108.28% 100.00%
P/EPS 113.10 84.31 76.99 325.52 38.44 58.36 61.27 10.75%
  YoY % 34.15% 9.51% -76.35% 746.83% -34.13% -4.75% -
  Horiz. % 184.59% 137.60% 125.66% 531.29% 62.74% 95.25% 100.00%
EY 0.88 1.19 1.30 0.31 2.60 1.71 1.63 -9.75%
  YoY % -26.05% -8.46% 319.35% -88.08% 52.05% 4.91% -
  Horiz. % 53.99% 73.01% 79.75% 19.02% 159.51% 104.91% 100.00%
DY 0.70 1.38 1.80 0.64 1.21 0.00 0.00 -
  YoY % -49.28% -23.33% 181.25% -47.11% 0.00% 0.00% -
  Horiz. % 57.85% 114.05% 148.76% 52.89% 100.00% - -
P/NAPS 2.78 3.15 2.27 2.58 1.95 1.36 1.24 14.39%
  YoY % -11.75% 38.77% -12.02% 32.31% 43.38% 9.68% -
  Horiz. % 224.19% 254.03% 183.06% 208.06% 157.26% 109.68% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS